Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine January 2011, 52 (1) 11A-12A;
  • Article
  • Info & Metrics
  • PDF
Loading

Folic acid radioconjugates: Müller and Schibli describe current folate receptor–targeting strategies and summarize the promise of several folic acid radioconjugates for SPECT and PET oncologic applications. Page 1

Figure

PET probe for melanoma: Minn and Vihinen offer commentary on current practices in PET staging of melanoma, focusing on a novel tracer described in this issue of JNM with potential for detection of regional lymph node metastases.Page 5

Cortical networks and PET: Kumar and Chugani review the use of 18F-FDG PET in elucidating cortical networks underlying a range of neurocognitive dysfunction and preview an article in this issue of JNM on its utility in postencephalitic epilepsy.Page 8

Vascular inflammation and PET: Yoo and colleagues use 18F-FDG PET to examine the severity of vascular inflammation in healthy individuals without hyperlipidemia but with elevated high-sensitivity C-reactive protein.Page 10

Time corrections of tumor SUVs: Stahl and colleagues present a simple, algebraically deduced method using a single reference point to make straightforward time corrections of tumor SUVs in 18F-FDG PET of breast cancer.Page 18

11C-PBR28 PET and translocator protein binding: Owen and colleagues explore whether mixed-affinity binding characteristics in multiple sclerosis can be detected in brain tissue and blood from individuals with no history of neurologic disease.Page 24

11C-PK11195 in vasculitides: Lamare and colleagues investigate whether PET/CT angiography using a selective ligand for the translocator protein 18 kDa, expressed in activated macrophages, can allow imaging and quantification of arterial wall inflammation in patients with large-vessel vasculitis.Page 33

Figure

PET in FIRES: Mazzuca and colleagues describe the utility of 18F-FDG PET in identifying the location of neocortical dysfunction in pediatric febrile infection–related epilepsy syndrome, a recently described entity of unknown etiology.Page 40

Figure

Monitoring antiangiogenic therapy response: de Langen and colleagues assess the predictive value of combined PET, CT, and MR data during antiangiogenic treatment in patients with advanced non–small cell lung cancer.Page 48

Figure

Follow-up scintigraphy in DTC: de Meer and colleagues question the value added by follow-up diagnostic radioiodine whole-body scintigraphy to recombinant human thyroid-stimulating hormone–stimulated thyroglobulin measurement in high-risk patients with differentiated thyroid cancer.Page 56

Myocardial OEF and dynamic 15O2 PET: Lubberink and colleagues determine the accuracy of oxygen extraction fraction measurements using a dynamic PET protocol after bolus inhalation of 15O2.Page 60

PET/CT after CRT: Uebleis and colleagues use electrocardiogram-gated 18F-FDG PET/CT to identify differences in responders and nonresponders to cardiac resynchronization therapy, with results that could inform alternative and individualized therapies for nonresponders.Page 67

Figure

Localization with 90Y PET/CT: Gates and colleagues evaluate the results of PET/CT imaging to determine 90Y glass microsphere distribution in patients after implantation for transarterial radiation treatment of liver tumors.Page 72

Figure

PET prediction in RA treatment: Elzinga and colleagues assess correlations between changes in 18F-FDG joint uptake on PET after only 2 wk of infliximab treatment and later clinical outcomes in patients with rheumatoid arthritis.Page 77

PET in prostate cancer: Jadvar provides an educational overview of the role of imaging in prostate cancer and the relative and respective capabilities of 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline in PET imaging in the disease.Page 81

Figure

PET, ICH, and stem cells: Feng and colleagues use serial 18F-FDG PET imaging to assess the efficacy of human mesenchymal stem cells in the treatment of intracerebral hematoma in a primate model.Page 90

Figure

Choline metabolism in HCC: Kuang and colleagues examine the relationship between choline metabolism and tracer uptake in 11C-choline PET imaging in an animal model of hepatocellular cancer.Page 98

Imaging TSPO expression in glioma: Buck and colleagues describe preclinical PET studies characterizing a high-affinity aryloxyanilide-based translator protein imaging ligand, a candidate probe for quantitative assessment of translator protein expression in glioma.Page 107

Figure

Melanoma lymphoscintigraphy with 18F-MEL050: Denoyer and colleagues detail the efficacy of differing routes of administration of a new benzamide-based PET radiotracer for imaging regional lymph node metastasis in melanoma.Page 115

68Ga-DOTATOC reporter gene imaging: Zhang and colleagues report on a series of validation studies of the human somatostatin receptor subtype 2–68Ga-DOTATOC reporter system and potential beneficial aspects in translation to clinical studies.Page 123

Figure

Comparing dopamine transporter tracers: Varrone and colleagues examine the kinetics and relative merits of 18F-FE-PE2I, a novel radioligand for dopamine transporter PET, and 11C-PE2I in nonhuman primates.Page 132

PET and Abraxane treatment: Sun and colleagues investigate whether 18F-FPPRGD2, an integrin-specific PET tracer, has utility in monitoring early response of breast tumors to Abraxane therapy in preclinical studies.Page 140

18F-PFH PET for renal imaging: Awasthi and colleagues explore the potential of p-18F-fluorohippurate for PET imaging to measure effective renal plasma flow and function.Page 147

MRI-assisted PET motion correction: Catana and colleagues apply a novel algorithm for data processing and rigid-body motion correction for an MRI-compatible PET brain scanner prototype and describe the results of phantom and human validation studies.Page 154

ON THE COVER

Head motion is difficult to avoid in long PET studies, degrading image quality and offsetting the benefit of using a high-resolution scanner. As a potential solution, simultaneously acquired MRI data can be used for motion tracking. The prototype dedicated brain scanner shown here, which can be operated inside the bore of an MRI scanner, has the potential to improve PET image quality and to benefit many neurologic applications.

See page 155.

Figure
  • © 2011 by Society of Nuclear Medicine
Next
Back to top

In this issue

Journal of Nuclear Medicine: 52 (1)
Journal of Nuclear Medicine
Vol. 52, Issue 1
January 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Jan 2011, 52 (1) 11A-12A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Jan 2011, 52 (1) 11A-12A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • ON THE COVER
  • Info & Metrics
  • PDF

Related Articles

  • Vascular Inflammation Stratified by C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels: Analysis with 18F-FDG PET
  • Improved Detection of Regional Melanoma Metastasis Using 18F-6-Fluoro-N-[2-(Diethylamino)Ethyl] Pyridine-3-Carboxamide, a Melanin-Specific PET Probe, by Perilesional Administration
  • The Role of Routine Diagnostic Radioiodine Whole-Body Scintigraphy in Patients with High-Risk Differentiated Thyroid Cancer
  • Imaging Lipid Synthesis in Hepatocellular Carcinoma with [Methyl-11C]Choline: Correlation with In Vivo Metabolic Studies
  • 18F-FDG PET Reveals Frontotemporal Dysfunction in Children with Fever-Induced Refractory Epileptic Encephalopathy
  • Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with 68Ga-DOTATOC
  • 18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy
  • Internal Pair Production of 90Y Permits Hepatic Localization of Microspheres Using Routine PET: Proof of Concept
  • Serial 18F-FDG PET Demonstrates Benefit of Human Mesenchymal Stem Cells in Treatment of Intracerebral Hematoma: A Translational Study in a Primate Model
  • Time Course of Tumor SUV in 18F-FDG PET of Breast Cancer: Presentation of a Simple Model Using a Single Reference Point for Time Corrections of Tumor SUVs
  • Delineating Cortical Networks Underlying Epileptic Encephalopathy and Cognitive Impairment with PET: A Perspective
  • Monitoring Response to Antiangiogenic Therapy in Non–Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI
  • 18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study
  • Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands
  • Electrocardiogram-Gated 18F-FDG PET/CT Hybrid Imaging in Patients with Unsatisfactory Response to Cardiac Resynchronization Therapy: Initial Clinical Results
  • Melanoma Imaging with Highly Specific PET Probes: Ready for Prime Time?
  • Folic Acid Conjugates for Nuclear Imaging of Folate Receptor–Positive Cancer
  • Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using 18F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline
  • Prostate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-Choline
  • Kinetic Analysis and Quantification of the Dopamine Transporter in the Nonhuman Primate Brain with 11C-PE2I and 18F-FE-PE2I
  • MRI-Assisted PET Motion Correction for Neurologic Studies in an Integrated MR-PET Scanner
  • Detection and Quantification of Large-Vessel Inflammation with 11C-(R)-PK11195 PET/CT
  • Myocardial Oxygen Extraction Fraction Measured Using Bolus Inhalation of 15O-Oxygen Gas and Dynamic PET
  • Synthesis and In Vivo Evaluation of p-18F-Fluorohippurate as a New Radiopharmaceutical for Assessment of Renal Function by PET
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire